Prime Medicine (PRME) Change in Acquisitions & Divestments (2021 - 2026)

Prime Medicine's Change in Acquisitions & Divestments history runs 6 years deep, the most recent figure standing at $50.9 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 1596.27% year-over-year to $50.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $143.7 million (up 306.72% YoY) and the FY2025 annual result came in at $95.8 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments was $50.9 million for Q1 2026 at Prime Medicine, up from $39.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $72.5 million in Q1 2024 and bottomed at -$171.3 million in Q4 2024.
• A 5-year average of $21.9 million and a median of $32.5 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments tumbled 460.37% — and 2026, when it jumped 1596.27%.
• Prime Medicine's Change in Acquisitions & Divestments stood at $25.0 million in 2022, then jumped by 90.14% to $47.5 million in 2023, then tumbled by 460.37% to -$171.3 million in 2024, then soared by 122.83% to $39.1 million in 2025, then jumped by 30.15% to $50.9 million in 2026.
• Business Quant data shows PRME's Change in Acquisitions & Divestments at $50.9 million in Q1 2026, $39.1 million in Q4 2025, and $42.4 million in Q3 2025.